Mealey's (December 20, 2018, 1:42 PM EST) -- TRENTON, N.J. — A patent owner’s attempt to invoke Noerr-Pennington immunity from antitrust counterclaims levied by a generic drug maker was deemed premature on Dec. 19, when a New Jersey federal judge denied the patent owner’s motion to dismiss (Takeda Pharmaceutical Company Ltd. v. Zydus Pharmaceuticals USA Inc., No. 18-1994, D. N.J., 2018 U.S. Dist. LEXIS 213473)....